|
|
|
| Prevalence of chronic diseases among residents in Xiamen City |
| CHEN Debin, SHEN Jinyu
|
| Department of Chronic Non-Communicable and Endemic Disease Control and Prevention, Xiamen Center for Disease Control and Prevention, Xiamen, Fujian 361021, China |
|
|
|
|
Abstract Objective To investigate the prevalence of major chronic diseases among residents in Xiamen City, Fujian Province, so as to provide insights into enhancing the prevention and control of chronic diseases. Methods The residents aged 18 years and older and lived for 6 months and more were selected from 6 districts in Xiamen City from 2021 to 2022 using the stratified random sampling method. Demographic information, disease history, blood pressure, fasting blood glucose and blood cholesterol were collected through questionnaire surveys, physical examination and laboratory tests. The prevalence rates of hypertension, diabetes and hypercholesterolemia were calculated and standardized using the 2020 National Population Census data, and were analyzed by age and gender. Results Totally 22 289 residents were investigated, including 10 444 males (46.86%) and 11 845 females (53.14%). The prevalence rates of hypertension, diabetes and hypercholesterolemia were 15.35%, 4.30% and 10.45%, and the standardized prevalence rates were 16.25%, 4.81% and 10.21%, respectively. The standardized prevalence rates of hypertension, diabetes and hypercholesterolemia in males were 19.20%, 5.71% and 9.97%, respectively, and were higher than those in females, which were 13.62%, 4.03% and 10.29%, respectively (all P<0.05). The crude prevalence rates of hypertension and diabetes in males aged 18 to 59 years were higher than those in females, the crude prevalence rate of hypercholesterolemia in males aged 18 to 49 years was higher than that in females, and the crude prevalence rate of hypercholesterolemia aged 50 years and over in males was lower than that in females (all P<0.05). Conclusion From 2017 to 2022, the prevalence rates of hypertension, diabetes, and hypercholesterolemia in males were higher than those in females in Xiamen City, while the prevalence rate of hypercholesterolemia in females was higher than that in males after the age of 50 years.
|
|
Received: 21 December 2023
Revised: 28 March 2024
Published: 19 July 2024
|
|
|
|
|
|
[1] 张洁,费方荣,胡如英,等.浙江省慢性病主要危险因素的归因疾病负担研究[J].预防医学,2022,34(6):541-546,554.
[2] 伍甜甜,朱娥,虞建英,等.湖南省成年居民慢性病患病现况及影响因素分析[J].预防医学,2022,34(11):1145-1149,1155.
[3] 李文燕. 2015年福建省分地市居民疾病负担研究[D].北京:中国疾病预防控制中心,2019.
[4] 林修全,陈铁晖,林熙,等.2018年福建省成人主要慢性病患病情况及危险因素分析[J].中国慢性病预防与控制,2022,30(7):485-490.
[5] 中国高血压防治指南修订委员会,高血压联盟(中国),中华医学会心血管病学分会,等.中国高血压防治指南(2018年修订版)[J].中国心血管杂志,2019,24(1):24-56.
[6] ALBERTI K G,ZIMMET P Z.Definition,diagnosis and classification of diabetes mellitus and its complications.Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J].Diabet Med,1998,15(7):539-553.
[7] 中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南(2016年修订版)[J].中华心血管病杂志,2016,44(10):833-853.
[8] 申锦玉,陈敏.厦门市居民慢性病及其危险因素调查分析[J].中国慢性病预防与控制,2017,25(10):738-741.
[9] 林黛茜,韩英,王叶舟,等.福建省高血压患病情况及影响因素分析[J].中华高血压杂志,2018,26(2):159-163.
[10] 王增武. 中国高血压流行和防治现状[J].中国心血管病研究,2022,20(8):673-678.
[11] BENJAMIN E J,BLAHA M J,CHIUVE S E,et al.Heart disease and stroke statistics-2017 update:a report from the American Heart Association[J].Circulation,2017,135(10):146-603.
[12] KALENGA C Z,METCALFE A,ROBERT M,et al.Association between the route of administration and formulation of estrogen therapy and hypertension risk in postmenopausal women:a prospective population-based study[J].Hypertension,2023,80(7):1463-1473.
[13] SRIVARATHARAJAH K,ABRAMSON B L.Hypertension in menopausal women:the effect and role of estrogen[J].Menopause,2019,26(4):428-430.
[14] MARQUES-LOPES J,VAN KEMPEN T,WATERS E M,et al.Slow-pressor angiotensin II hypertension and concomitant dendritic NMDA receptor trafficking in estrogen receptor beta-containing neurons of the mouse hypothalamic paraventricular nucleus are sex and age dependent[J].J Comp Neurol,2014,522(13):3075-3090.
[15] 陈铁晖,李文燕,钟文玲,等.福建省成年居民糖尿病流行特征及其影响因素[J].慢性病学杂志,2017,18(9):957-961.
[16] 马越,孔祥婕,彭雯,等.中国糖尿病疾病负担现状及趋势[J].中国预防医学杂志,2023,24(4):281-286.
[17] NG R,SUTRADHAR R,YAO Z,et al.Smoking,drinking,diet and physical activity-modifiable lifestyle risk factors and their associations with age to first chronic disease[J].Int J Epidemiol,2020,49(1):113-130.
[18] 闵瑞,徐焱成.发病年龄与初诊2型糖尿病患者酮症的关系[J].公共卫生与预防医学,2021,32(2):59-63.
[19] 何伟林. 中国队列人群高胆固醇血症发病率及其影响因素[D].北京:北京协和医学院,2018.
[20] 姜博,马爱娟,李航,等.北京市18~65岁居民高胆固醇血症流行现状与影响因素分析[J].中华流行病学杂志,2017,38(7):938-943.
[21] PANAGIOTAKOS D B,PITSAVOS C,SKOUMAS Y,et al.Abdominal obesity,blood glucose and apolipoprotein B levels are the best predictors of the incidence of hypercholesterolemia(2001-2006)among healthy adults:the ATTICA study[J/OL].Lipids Health Dis,2008,7[2024-03-28].https://doi.org/10.1186/1476-511X-7-11.
[22] YANG W Y,XIAO J Z,YANG Z J,et al.Serum lipids and lipoproteins in Chinese men and women[J].Circulation,2012,125(18):2212-2221. |
|
|
|
